Abstract Number: 1533 • 2015 ACR/ARHP Annual Meeting
Age Related Disability in Daily Life Should be Considered in Older Than Sixty-Five-Year-Old Rheumatoid Arthritis Patient
Background/Purpose: In treating rheumatoid arthritis (RA), patient’s activity in daily life (ADL) is extremely important factor, because RA is chronic inflammatory disease that leads discomfort…Abstract Number: 1534 • 2015 ACR/ARHP Annual Meeting
Temporal Trends and Outcomes of Acute Myocardial Infarction in Rheumatoid Arthritis Hospitalizations
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased risk of cardiac mortality. With better treatment modalities, some studies suggest that infarction (AMI) mortality in RA…Abstract Number: 1535 • 2015 ACR/ARHP Annual Meeting
The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study
Background/Purpose: Obesity has recently been spotlighted as an important comorbidity in rheumatoid arthritis (RA); not only associated with disease severity but also its development. Despite…Abstract Number: 1536 • 2015 ACR/ARHP Annual Meeting
Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients without Traditional Cardiovascular Risk Factors
Background/Purpose: Rheumatoid arthritis (RA) is characterized by inflammation of the synovial membrane of the diarthrodial joints which include arthrodesis of the middle ear, (incudomalleolar and…Abstract Number: 1537 • 2015 ACR/ARHP Annual Meeting
Effect of TNF-Alpha Blockade on Body Composition in Inflammatory Rheumatic Disease: Systematic Review with Meta-Analysis
Background/Purpose: Patients with chronic inflammatory rheumatic disease have elevated circulating concentrations of TNF-alpha and other pro-inflammatory cytokines that can modify body composition. Metabolic changes are…Abstract Number: 1538 • 2015 ACR/ARHP Annual Meeting
Clinical Analysis of 30 Rheumatoid Arthritis Patients Complicated with Malignant Lymphoma, Especially Methotrexate-Related Lymphoproliferative Disorder
Background/Purpose: Recently, methotrexate (MTX) has been considered as the anchor drug in the treatment of rheumatoid arthritis (RA). However, it has been reported that MTX…Abstract Number: 1539 • 2015 ACR/ARHP Annual Meeting
Control of Modifiable Cardiovascular Risk Factors in Rheumatoid Arthritis Patients Compared to Traditional High-Risk Cardiovascular Disease Patients
Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease affecting one percent of the population. The main cause of mortality among RA patients…Abstract Number: 1540 • 2015 ACR/ARHP Annual Meeting
Cardiovascular Risk Management in Rheumatoid Arthritis Patients
Background/Purpose: Rheumatoid arthritis (RA) patients have been previously shown to have a higher cardiovascular (CV) burden as compared to the general population. The CV risk…Abstract Number: 1541 • 2015 ACR/ARHP Annual Meeting
Subgroups of Established Rheumatoid Arthritis Patients Can be Characterized By Patient and Physician Assessment Discrepancy, Anxiety and Depression and Presence of Depression Might be Associated with Slower Response to Treatment
Background/Purpose: Rheumatoid arthritis (RA) is a heterogeneous inflammatory disease with various signs and symptoms. Previous studies have shown that RA patients can be sub-grouped based…Abstract Number: 1542 • 2015 ACR/ARHP Annual Meeting
Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis
Background/Purpose: Arterial vascular events have a great impact in the morbidity and mortality of rheumatoid arthritis (RA). Traditional and nontraditional risk factors for arterial vascular…Abstract Number: 1543 • 2015 ACR/ARHP Annual Meeting
Traditional Risk Score Underestimates the Cardiovascular Risk in Rheumatoid Arthritis Patients
Background/Purpose: An increased incidence of cardiovascular (CV) mortality has been reported in patients with rheumatoid arthritis (RA). Adequate stratification of the CV risk is an…Abstract Number: 1544 • 2015 ACR/ARHP Annual Meeting
Resiliency As a Predictor of Depressive Symptoms in Patients with Rheumatoid Arthritis
Background/Purpose: Rheumatoid arthritis is a chronic, systemic, autoimmune disease affecting 0.5 – 1% of the adult population that leads to a progressive decline in functional…Abstract Number: 1545 • 2015 ACR/ARHP Annual Meeting
Comparison of Statin Eligibility According to the Adult Treatment Panel III, ACC/AHA Blood Cholesterol Guideline and Presence of Carotid Plaque By Ultrasound in Hispanics with Rheumatoid Arthritis
Background/Purpose: Atherosclerotic cardiovascular disease (ASCVD) is the number one cause of death in rheumatoid arthritis (RA) patients. RA itself is an independent risk factor for…Abstract Number: 1546 • 2015 ACR/ARHP Annual Meeting
What Is the Impact of Smoking on the Risk of Rheumatoid Arthritis Progression: A Systematic Review of the Risk Factor Paradox
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to progressive joint deformity, destruction, and disability. While smoking is recognized as a strong…Abstract Number: 1547 • 2015 ACR/ARHP Annual Meeting
Implementing an Electronic Medical Recorded-Based Clinical Decision Support Tool Did Not Improve Cardiovascular Risk Screening in Rheumatoid Arthritis Patients
Background/Purpose: Cardiovascular disease (CVD) is the leading cause of death among individuals with rheumatoid arthritis (RA). The 2010 EULAR guidelines recommend annual CV risk assessment…
ACR Meeting Abstracts